Product Information
CYCLOBENZAPRINE 7.5 MG TABLET is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.2600 per EA under NDC 29300041401. Its NADAC has been published 280 times since Nov 18, 2020.
Strength
7.5 mg/1
Manufacturer
Unichem Pharmaceuticals (USA) Inc.NDC
29300041401
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213324On Market Since
7/6/2020
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 7.5 MG TABLET has been published 280 times since Nov 18, 2020, and over the history we have for it it has declined 80.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2600 per EA |
|---|---|
| All-time high | $1.4342 (Jul 14, 2021) |
| All-time low | $0.2600 (Jun 17, 2026) |
| 52-week high | $0.3669 |
| 52-week low | $0.2600 |
| Median price | $0.3982 |
| Average price | $0.6237 |
| Largest weekly change | -68.4% (Oct 19, 2022) |
| Weeks tracked | 280 |
| Tracking since | Nov 18, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Cyclobenzaprine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 7.5 MG TABLET, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.2600 per EA (NDC 29300041401), effective Jun 24, 2026.
How has the price of CYCLOBENZAPRINE 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 7.5 MG TABLET has declined 80.3%. It has been tracked across 280 weekly CMS publications since Nov 18, 2020.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 7.5 MG TABLET?
Since Nov 18, 2020, the NADAC for CYCLOBENZAPRINE 7.5 MG TABLET has ranged from a low of $0.2600 (Jun 17, 2026) to a high of $1.4342 (Jul 14, 2021), with a median of $0.3982 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 7.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CYCLOBENZAPRINE 7.5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures CYCLOBENZAPRINE 7.5 MG TABLET?
CYCLOBENZAPRINE 7.5 MG TABLET (NDC 29300041401) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification